The global Cytotoxicity Testing Services market size is predicted to grow from US$ 150 million in 2025 to US$ 218 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Cytotoxicity testing services involve the evaluation of the toxicity of substances (such as chemicals, drugs, biomaterials, or medical devices) on cells. These services are crucial in various fields including pharmaceuticals, cosmetics, biomaterials research, and environmental science. The main goal is to determine whether a test substance has the potential to damage or kill cells, which can provide important information about its safety and biocompatibility.
United States market for Cytotoxicity Testing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cytotoxicity Testing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cytotoxicity Testing Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cytotoxicity Testing Services players cover UL, SGS, iuvo BioScience, Sartorius, Eurofins Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐ytotoxicity Testing Services Industry Forecast鈥� looks at past sales and reviews total world Cytotoxicity Testing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Cytotoxicity Testing Services sales for 2025 through 2031. With Cytotoxicity Testing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cytotoxicity Testing Services industry.
This Insight Report provides a comprehensive analysis of the global Cytotoxicity Testing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cytotoxicity Testing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cytotoxicity Testing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cytotoxicity Testing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cytotoxicity Testing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Cytotoxicity Testing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Segmentation by Application:
Drug
Medical Instruments
Cosmetics and Personal Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
UL
SGS
iuvo BioScience
Sartorius
Eurofins Scientific
T脺V S脺D
Nelson Labs
Pacific BioLabs
Emery Pharma
UFAG Laboratorien AG
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
Medicilon
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Cytotoxicity Testing Services 麻豆原创 Size (2020-2031)
2.1.2 Cytotoxicity Testing Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cytotoxicity Testing Services by Country/Region (2020, 2024 & 2031)
2.2 Cytotoxicity Testing Services Segment by Type
2.2.1 Elution Testing Method
2.2.2 Agar Overlay Method
2.2.3 Direct Contact Method
2.2.4 MTT Assay Method
2.2.5 Others
2.3 Cytotoxicity Testing Services 麻豆原创 Size by Type
2.3.1 Cytotoxicity Testing Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cytotoxicity Testing Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Cytotoxicity Testing Services Segment by Application
2.4.1 Drug
2.4.2 Medical Instruments
2.4.3 Cosmetics and Personal Care
2.4.4 Others
2.5 Cytotoxicity Testing Services 麻豆原创 Size by Application
2.5.1 Cytotoxicity Testing Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cytotoxicity Testing Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Cytotoxicity Testing Services 麻豆原创 Size by Player
3.1 Cytotoxicity Testing Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Cytotoxicity Testing Services Revenue by Player (2020-2025)
3.1.2 Global Cytotoxicity Testing Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Cytotoxicity Testing Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cytotoxicity Testing Services by Region
4.1 Cytotoxicity Testing Services 麻豆原创 Size by Region (2020-2025)
4.2 Global Cytotoxicity Testing Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cytotoxicity Testing Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC Cytotoxicity Testing Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe Cytotoxicity Testing Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Cytotoxicity Testing Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Cytotoxicity Testing Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas Cytotoxicity Testing Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas Cytotoxicity Testing Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cytotoxicity Testing Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC Cytotoxicity Testing Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC Cytotoxicity Testing Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cytotoxicity Testing Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe Cytotoxicity Testing Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe Cytotoxicity Testing Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cytotoxicity Testing Services by Region (2020-2025)
8.2 Middle East & Africa Cytotoxicity Testing Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Cytotoxicity Testing Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Cytotoxicity Testing Services 麻豆原创 Forecast
10.1 Global Cytotoxicity Testing Services Forecast by Region (2026-2031)
10.1.1 Global Cytotoxicity Testing Services Forecast by Region (2026-2031)
10.1.2 Americas Cytotoxicity Testing Services Forecast
10.1.3 APAC Cytotoxicity Testing Services Forecast
10.1.4 Europe Cytotoxicity Testing Services Forecast
10.1.5 Middle East & Africa Cytotoxicity Testing Services Forecast
10.2 Americas Cytotoxicity Testing Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Cytotoxicity Testing Services Forecast
10.2.2 Canada 麻豆原创 Cytotoxicity Testing Services Forecast
10.2.3 Mexico 麻豆原创 Cytotoxicity Testing Services Forecast
10.2.4 Brazil 麻豆原创 Cytotoxicity Testing Services Forecast
10.3 APAC Cytotoxicity Testing Services Forecast by Region (2026-2031)
10.3.1 China Cytotoxicity Testing Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Cytotoxicity Testing Services Forecast
10.3.3 Korea 麻豆原创 Cytotoxicity Testing Services Forecast
10.3.4 Southeast Asia 麻豆原创 Cytotoxicity Testing Services Forecast
10.3.5 India 麻豆原创 Cytotoxicity Testing Services Forecast
10.3.6 Australia 麻豆原创 Cytotoxicity Testing Services Forecast
10.4 Europe Cytotoxicity Testing Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Cytotoxicity Testing Services Forecast
10.4.2 France 麻豆原创 Cytotoxicity Testing Services Forecast
10.4.3 UK 麻豆原创 Cytotoxicity Testing Services Forecast
10.4.4 Italy 麻豆原创 Cytotoxicity Testing Services Forecast
10.4.5 Russia 麻豆原创 Cytotoxicity Testing Services Forecast
10.5 Middle East & Africa Cytotoxicity Testing Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Cytotoxicity Testing Services Forecast
10.5.2 South Africa 麻豆原创 Cytotoxicity Testing Services Forecast
10.5.3 Israel 麻豆原创 Cytotoxicity Testing Services Forecast
10.5.4 Turkey 麻豆原创 Cytotoxicity Testing Services Forecast
10.6 Global Cytotoxicity Testing Services Forecast by Type (2026-2031)
10.7 Global Cytotoxicity Testing Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Cytotoxicity Testing Services Forecast
11 Key Players Analysis
11.1 UL
11.1.1 UL Company Information
11.1.2 UL Cytotoxicity Testing Services Product Offered
11.1.3 UL Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 UL Main Business Overview
11.1.5 UL Latest Developments
11.2 SGS
11.2.1 SGS Company Information
11.2.2 SGS Cytotoxicity Testing Services Product Offered
11.2.3 SGS Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 SGS Main Business Overview
11.2.5 SGS Latest Developments
11.3 iuvo BioScience
11.3.1 iuvo BioScience Company Information
11.3.2 iuvo BioScience Cytotoxicity Testing Services Product Offered
11.3.3 iuvo BioScience Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 iuvo BioScience Main Business Overview
11.3.5 iuvo BioScience Latest Developments
11.4 Sartorius
11.4.1 Sartorius Company Information
11.4.2 Sartorius Cytotoxicity Testing Services Product Offered
11.4.3 Sartorius Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Sartorius Main Business Overview
11.4.5 Sartorius Latest Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Information
11.5.2 Eurofins Scientific Cytotoxicity Testing Services Product Offered
11.5.3 Eurofins Scientific Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Eurofins Scientific Main Business Overview
11.5.5 Eurofins Scientific Latest Developments
11.6 T脺V S脺D
11.6.1 T脺V S脺D Company Information
11.6.2 T脺V S脺D Cytotoxicity Testing Services Product Offered
11.6.3 T脺V S脺D Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 T脺V S脺D Main Business Overview
11.6.5 T脺V S脺D Latest Developments
11.7 Nelson Labs
11.7.1 Nelson Labs Company Information
11.7.2 Nelson Labs Cytotoxicity Testing Services Product Offered
11.7.3 Nelson Labs Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Nelson Labs Main Business Overview
11.7.5 Nelson Labs Latest Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Information
11.8.2 Pacific BioLabs Cytotoxicity Testing Services Product Offered
11.8.3 Pacific BioLabs Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Pacific BioLabs Main Business Overview
11.8.5 Pacific BioLabs Latest Developments
11.9 Emery Pharma
11.9.1 Emery Pharma Company Information
11.9.2 Emery Pharma Cytotoxicity Testing Services Product Offered
11.9.3 Emery Pharma Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Emery Pharma Main Business Overview
11.9.5 Emery Pharma Latest Developments
11.10 UFAG Laboratorien AG
11.10.1 UFAG Laboratorien AG Company Information
11.10.2 UFAG Laboratorien AG Cytotoxicity Testing Services Product Offered
11.10.3 UFAG Laboratorien AG Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 UFAG Laboratorien AG Main Business Overview
11.10.5 UFAG Laboratorien AG Latest Developments
11.11 NorthEast BioLab
11.11.1 NorthEast BioLab Company Information
11.11.2 NorthEast BioLab Cytotoxicity Testing Services Product Offered
11.11.3 NorthEast BioLab Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 NorthEast BioLab Main Business Overview
11.11.5 NorthEast BioLab Latest Developments
11.12 Biosafe Ltd
11.12.1 Biosafe Ltd Company Information
11.12.2 Biosafe Ltd Cytotoxicity Testing Services Product Offered
11.12.3 Biosafe Ltd Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Biosafe Ltd Main Business Overview
11.12.5 Biosafe Ltd Latest Developments
11.13 Creative Bioarray
11.13.1 Creative Bioarray Company Information
11.13.2 Creative Bioarray Cytotoxicity Testing Services Product Offered
11.13.3 Creative Bioarray Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Creative Bioarray Main Business Overview
11.13.5 Creative Bioarray Latest Developments
11.14 Evercyte
11.14.1 Evercyte Company Information
11.14.2 Evercyte Cytotoxicity Testing Services Product Offered
11.14.3 Evercyte Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Evercyte Main Business Overview
11.14.5 Evercyte Latest Developments
11.15 IONTOX
11.15.1 IONTOX Company Information
11.15.2 IONTOX Cytotoxicity Testing Services Product Offered
11.15.3 IONTOX Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 IONTOX Main Business Overview
11.15.5 IONTOX Latest Developments
11.16 Applied StemCell
11.16.1 Applied StemCell Company Information
11.16.2 Applied StemCell Cytotoxicity Testing Services Product Offered
11.16.3 Applied StemCell Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Applied StemCell Main Business Overview
11.16.5 Applied StemCell Latest Developments
11.17 Xenometrix AG
11.17.1 Xenometrix AG Company Information
11.17.2 Xenometrix AG Cytotoxicity Testing Services Product Offered
11.17.3 Xenometrix AG Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Xenometrix AG Main Business Overview
11.17.5 Xenometrix AG Latest Developments
11.18 Medicilon
11.18.1 Medicilon Company Information
11.18.2 Medicilon Cytotoxicity Testing Services Product Offered
11.18.3 Medicilon Cytotoxicity Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Medicilon Main Business Overview
11.18.5 Medicilon Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.